feedburner

Enter your email address:

Delivered by FeedBurner

Glenmark gets final nod from USFDA for angina treatment drug

The product is a generic version of Gilead Sciences Inc's Ranexa
extended-release tablets in the same strengths.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-final-nod-from-usfda-for-angina-treatment-drug/articleshow/70141399.cms



0 comments:

Post a Comment